GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (OTCPK:SNBIF) » Definitions » Revenue

SanBio Co (SanBio Co) Revenue : $0.00 Mil (TTM As of Jan. 2024)


View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Revenue?

SanBio Co's revenue for the three months ended in Jan. 2024 was $0.00 Mil. Its revenue for the trailing twelve months (TTM) ended in Jan. 2024 was $0.00 Mil. SanBio Co's Revenue per Share for the three months ended in Jan. 2024 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 11 years, SanBio Co's highest 3-Year average Revenue per Share Growth Rate was 58.20% per year. The lowest was -49.20% per year. And the median was -21.35% per year.


SanBio Co Revenue Historical Data

The historical data trend for SanBio Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co Revenue Chart

SanBio Co Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.09 - - - -

SanBio Co Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of SanBio Co's Revenue

For the Biotechnology subindustry, SanBio Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SanBio Co's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SanBio Co's Revenue distribution charts can be found below:

* The bar in red indicates where SanBio Co's Revenue falls into.



SanBio Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SanBio Co  (OTCPK:SNBIF) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


SanBio Co Revenue Related Terms

Thank you for viewing the detailed overview of SanBio Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


SanBio Co (SanBio Co) Business Description

Traded in Other Exchanges
Address
8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

SanBio Co (SanBio Co) Headlines

From GuruFocus

Full Year 2021 SanBio Co Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q2 2021 SanBio Co Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q2 2022 SanBio Co Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Full Year 2023 SanBio Co Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q2 2019 SanBio Co Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Q2 2024 SanBio Co Ltd Earnings Presentation Transcript

By GuruFocus Research 02-15-2024